Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Down 4.1% - Should You Sell?

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report)'s stock price dropped 4.1% during mid-day trading on Monday . The company traded as low as $7.50 and last traded at $7.55. Approximately 93,530 shares traded hands during trading, a decline of 88% from the average daily volume of 784,465 shares. The stock had previously closed at $7.87.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on BAYRY. Hsbc Global Res raised Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, June 11th. The Goldman Sachs Group raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th. Wall Street Zen upgraded shares of Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research report on Thursday, June 26th. Finally, Kepler Capital Markets raised Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a report on Wednesday, June 11th. One research analyst has rated the stock with a hold rating, two have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Buy".

Bayer Aktiengesellschaft Stock Down 1.4%

The stock has a fifty day moving average of $7.18 and a 200-day moving average of $6.20. The firm has a market capitalization of $30.14 billion, a price-to-earnings ratio of -8.34 and a beta of 0.86. The company has a current ratio of 1.25, a quick ratio of 0.79 and a debt-to-equity ratio of 1.07.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported $0.65 earnings per share for the quarter, beating analysts' consensus estimates of $0.63 by $0.02. The business had revenue of $15.27 billion during the quarter, compared to analyst estimates of $13.39 billion. Bayer Aktiengesellschaft had a positive return on equity of 13.94% and a negative net margin of 7.26%. As a group, sell-side analysts expect that Bayer Aktiengesellschaft will post 1.31 EPS for the current year.

Bayer Aktiengesellschaft Increases Dividend

The company also recently announced a dividend, which was paid on Monday, May 12th. Stockholders of record on Wednesday, April 30th were given a $0.0224 dividend. This is an increase from Bayer Aktiengesellschaft's previous dividend of $0.02. This represents a dividend yield of 0.38%. The ex-dividend date was Tuesday, April 29th. Bayer Aktiengesellschaft's dividend payout ratio (DPR) is -2.17%.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.